{"DataElement":{"publicId":"6617621","version":"1","preferredName":"Prior Therapy Cancer Therapeutic Procedure Type","preferredDefinition":"Clarification of type of previously administered anti-cancer therapy.","longName":"PR_ANTI_CNCR_TX_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6617609","version":"1","preferredName":"Prior Therapy Cancer Therapeutic Procedure","preferredDefinition":"An indicator that a person has been previously treated for the same condition or with the same therapy._Any intervention for management of a malignant neoplasm.","longName":"2747595v1.0:4024871v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2747595","version":"1","preferredName":"Prior Therapy","preferredDefinition":"An indicator that a person has been previously treated for the same condition or with the same therapy.","longName":"C16124","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior Therapy","conceptCode":"C16124","definition":"Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96D31E-7E98-213E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"ONEDATA","dateModified":"2008-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4024871","version":"1","preferredName":"Cancer Treatment","preferredDefinition":"Any intervention for management of a malignant neoplasm.","longName":"C16212","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Therapeutic Procedure","conceptCode":"C16212","definition":"Any intervention for management of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEAAD09-56DF-3B4B-E040-BB89AD4335EB","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-12-19","modifiedBy":"ONEDATA","dateModified":"2013-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC50860-EE1F-524F-E053-F662850AA222","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6617611","version":"1","preferredName":"Prior Therapy Type","preferredDefinition":"An indicator that a person has been previously treated for the same condition or with the same therapy._Something distinguishable as an identifiable class based on common qualities.","longName":"6617611v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Chemotherapy cytotoxic","valueDescription":"Not Otherwise Specified Chemotherapy","ValueMeaning":{"publicId":"6617617","version":"1","preferredName":"Not Otherwise Specified Chemotherapy","longName":"6617617","preferredDefinition":"Not characterized in any other way.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-92B8-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80A26C73-A63A-4C2E-E053-F662850AFCF8","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-29","modifiedBy":"ONEDATA","dateModified":"2019-01-29","deletedIndicator":"No"},{"value":"Antibody therapy","valueDescription":"Antibody Therapy","ValueMeaning":{"publicId":"6620407","version":"1","preferredName":"Antibody Therapy","longName":"6620407","preferredDefinition":"Treatment with injections of antibodies made in another animal or in the laboratory.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibody Therapy","conceptCode":"C15542","definition":"Treatment with injections of antibodies to directly destroy specific, usually cancerous, cells or to stimulate the immune system to destroy those cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80A284BD-65FC-7509-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2019-01-29","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-29","modifiedBy":"KUMMEROA","dateModified":"2022-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80A284BD-6615-7509-E053-F662850A5839","beginDate":"2019-01-29","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-29","modifiedBy":"ONEDATA","dateModified":"2019-01-29","deletedIndicator":"No"},{"value":"Therapy NOS","valueDescription":"Not Otherwise Specified Therapeutic Procedure","ValueMeaning":{"publicId":"6617612","version":"1","preferredName":"Not Otherwise Specified Therapeutic Procedure","longName":"6617612","preferredDefinition":"Not characterized in any other way.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-91F6-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-920F-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Prior therapy NOS","valueDescription":"Other Prior Therapy","ValueMeaning":{"publicId":"6617614","version":"1","preferredName":"Other Prior Therapy","longName":"6617614","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Prior Therapy","conceptCode":"C16172","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-921C-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9235-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Oncolytic virotherapy","valueDescription":"Oncolytic Virotherapy","ValueMeaning":{"publicId":"2563827","version":"1","preferredName":"Oncolytic Virotherapy","longName":"2563827","preferredDefinition":"Treatment using an oncolytic virus (a virus that infects and breaks down cancer cells but not normal cells). Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncolytic Virus Therapy","conceptCode":"C62713","definition":"A targeted therapy that uses viral infection to cause the lysis of tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C660-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-23","modifiedBy":"REEVESD","dateModified":"2014-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-923F-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Image Directed Local Therapy","valueDescription":"Image-Guided Local Therapy","ValueMeaning":{"publicId":"6617616","version":"1","preferredName":"Image-Guided Local Therapy","longName":"6617616","preferredDefinition":"The use of imaging techniques to target treatment to a specific anatomic location or region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Image-Guided Local Therapy","conceptCode":"C118619","definition":"The use of imaging techniques to target treatment to a specific anatomic location or region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-924C-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9265-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Hormonal therapy","valueDescription":"Endocrine Therapy","ValueMeaning":{"publicId":"4340414","version":"1","preferredName":"Endocrine Therapy","longName":"4340414","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA223A1-46B7-E4F0-E040-BB89AD436356","latestVersionIndicator":"Yes","beginDate":"2014-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-05-30","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9279-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Gene transfer","valueDescription":"Gene Transfer","ValueMeaning":{"publicId":"2571541","version":"1","preferredName":"Gene Transfer","longName":"2571541","preferredDefinition":"Incorporation of new DNA into an organism's cells, usually by a vector such as a modified virus. Used in gene therapy.(From Human Genome Project Information).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Transfer","conceptCode":"C20185","definition":"Incorporation of new DNA into an organism's cells, usually by a vector such as a modified virus. Used in gene therapy.(From Human Genome Project Information).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E482-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-13","modifiedBy":"REEVESD","dateModified":"2006-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9283-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Chemotherapy non-cytotoxic","valueDescription":"Non-Cytotoxic Chemotherapy","ValueMeaning":{"publicId":"2571542","version":"1","preferredName":"Non-Cytotoxic Chemotherapy","longName":"2571542v1.00","preferredDefinition":"Chemotherapy using a pharmacologic agent that does not directly kill cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Cytotoxic Chemotherapy","conceptCode":"C118620","definition":"Chemotherapy using a pharmacologic agent that does not directly kill cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E483-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-92AB-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Antisense therapy","valueDescription":"Antisense Therapy","ValueMeaning":{"publicId":"2571539","version":"1","preferredName":"Antisense Therapy","longName":"2571539","preferredDefinition":"Antisense Oligonucleotide Therapy","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antisense Therapy","conceptCode":"C16236","definition":"Treatment using nucleic acid oligomers to bind to specific mRNA to deter protein production and alter disease process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E480-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-13","modifiedBy":"CURTIST","dateModified":"2007-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-92E5-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Antiretroviral therapy","valueDescription":"Antiretroviral Therapy","ValueMeaning":{"publicId":"2738677","version":"1","preferredName":"Antiretroviral Therapy","longName":"2738677","preferredDefinition":"Treatment of retroviral infections with medications that target the virus directly, limiting the ability of infected cells to produce new virus particles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiretroviral Therapy","conceptCode":"C94631","definition":"Treatment of retroviral infections with medications that target the virus directly, limiting the ability of infected cells to produce new virus particles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49E7530B-6430-6451-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-02","modifiedBy":"TSESU","dateModified":"2023-01-04","changeDescription":"02/19/2015 - tc - Updated with NCIt concept.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-92F9-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Vaccine (anti-tumor)","valueDescription":"Antineoplastic Agent Vaccine","ValueMeaning":{"publicId":"6617618","version":"1","preferredName":"Antineoplastic Agent Vaccine","longName":"6617618","preferredDefinition":"A substance that inhibits the maturation, growth or spread of tumor cells.: Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antineoplastic Agent","conceptCode":"C274","definition":"A substance that inhibits the maturation, growth or spread of tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-9306-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-931F-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Surgery","valueDescription":"Surgery","ValueMeaning":{"publicId":"2912042","version":"1","preferredName":"Surgery","longName":"2912042","preferredDefinition":"A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D923AEB-A778-BFCF-E040-BB89AD433C9F","latestVersionIndicator":"Yes","beginDate":"2009-06-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9329-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Radiation therapy","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"2567129","version":"1","preferredName":"Radiation Therapy","longName":"2567129","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D346-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9333-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"MIBG therapy","valueDescription":"Therapy Iobenguane","ValueMeaning":{"publicId":"6617619","version":"1","preferredName":"Therapy Iobenguane","longName":"6617619","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.: A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-9340-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-9359-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"},{"value":"Hematopoietic Stem Cell Transplantation","valueDescription":"Hematopoietic Cell Transplantation","ValueMeaning":{"publicId":"4395931","version":"1","preferredName":"Hematopoietic Cell Transplantation","longName":"4395931","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEBB1E93-3F07-E882-E040-BB89AD431336","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-21","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FC591D6-936D-36E8-E053-F662850AEFC2","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6617610","version":"1","preferredName":"Prior Therapy Type","preferredDefinition":"An indicator that a person has been previously treated for the same condition or with the same therapy.:Something distinguishable as an identifiable class based on common qualities.","longName":"C16124:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior Therapy","conceptCode":"C16124","definition":"Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-91CD-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"ONEDATA","dateModified":"2019-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC591D6-91DE-36E8-E053-F662850AEFC2","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Prior anti-cancer therapy typ","type":"Preferred Question Text","description":"Prior anti-cancer therapy type(s)","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC5A1C7-5DF6-3774-E053-F662850A7950","latestVersionIndicator":"Yes","beginDate":"2019-01-18","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-18","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":"Curated for ANBL1821 to include therapy types not listed in caDSR standard CDE 2008450.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}